We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$135M
Cap. Flow
+$22.1M
Cap. Flow %
1.32%
Top 10 Hldgs %
32.92%
Holding
336
New
30
Increased
77
Reduced
81
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.9M
2
STI
SunTrust Banks, Inc.
STI
+$17M
3
APTV icon
Aptiv
APTV
+$15.8M
4
INTC icon
Intel
INTC
+$13.5M
5
CRM icon
Salesforce
CRM
+$12.6M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$27.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$24.2M
3
PANW icon
Palo Alto Networks
PANW
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$17.1M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Industrials 18.82%
2 Communication Services 14.56%
3 Healthcare 11.18%
4 Technology 10.25%
5 Consumer Discretionary 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
101
Boston Scientific
BSX
$68.4B
$759K 0.05%
30,500
-2,040
-6% -$49.6K
STLA icon
102
Stellantis
STLA
$17.4B
$710K 0.04%
65,260
-15,060
-19% -$162K
ABB
103
DELISTED
ABB Ltd
ABB
$702K 0.04%
30,000
J icon
104
Jacobs Solutions
J
$16B
$691K 0.04%
+15,112
New +$715K
NVO
105
Novo Nordisk
NVO
$228B
$686K 0.04%
40,000
FLR icon
106
Fluor
FLR
$6.54B
$684K 0.04%
13,000
+9,000
+225% +$491K
MMM icon
107
3M
MMM
$91.8B
$665K 0.04%
4,160
-6,817
-62% -$1.05M
VALE icon
108
Vale
VALE
$62.3B
$665K 0.04%
70,000
+5,000
+8% +$49.7K
RCI icon
109
Rogers Communications
RCI
$18.8B
$661K 0.04%
15,000
BIDU icon
110
Baidu
BIDU
$35.7B
$656K 0.04%
3,800
+1,990
+110% +$350K
RDS.A
111
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$654K 0.04%
12,400
-148
-1% -$7.92K
TBT icon
112
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$646K 0.04%
16,500
-1,000
-6% -$39.9K
NTT
113
DELISTED
Nippon Telegraph & Telephone
NTT
$643K 0.04%
15,000
PHG icon
114
Philips
PHG
$25.5B
$642K 0.04%
27,011
-200
-0.7% -$4.49K
ENB icon
115
Enbridge
ENB
$120B
$636K 0.04%
15,196
+196
+1% +$8.28K
SKM icon
116
SK Telecom
SKM
$11.4B
$630K 0.04%
15,175
MBLY
117
DELISTED
Mobileye N.V.
MBLY
$614K 0.04%
10,000
-17,000
-63% -$818K
CP icon
118
Canadian Pacific Kansas City
CP
$81B
$613K 0.04%
20,875
TMO icon
119
Thermo Fisher Scientific
TMO
$214B
$599K 0.04%
3,902
+1,675
+75% +$256K
OVV icon
120
Ovintiv
OVV
$17B
$586K 0.04%
10,000
-1,000
-9% -$59.9K
BRK.B icon
121
Berkshire Hathaway Class B
BRK.B
$1.1T
$580K 0.03%
3,480
-1,460
-30% -$244K
LHX icon
122
L3Harris
LHX
$55.4B
$556K 0.03%
5,000
CX icon
123
Cemex
CX
$16.9B
$554K 0.03%
63,544
+21,372
+51% +$180K
PUK icon
124
Prudential
PUK
$36.4B
$551K 0.03%
13,403
USO icon
125
United States Oil Fund
USO
$2.15B
$547K 0.03%
6,425
-2,371
-27% -$210K

Similar funds

R.H. Bluestein & Co's Q1 2017 Portfolio in Review

As of Q1 2017, R.H. Bluestein & Co held 336 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

R.H. Bluestein & Co's Q1 2017 filing shows 30 new, 77 increased, 81 reduced and 11 closed positions. Its largest new stake was SunTrust Banks, Inc.: 296,401 shares worth $16.4M. The largest sale was Monsanto Co, an estimated $27.3M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.

  • R.H. Bluestein & Co's largest Q1 2017 buy was SunTrust Banks, Inc.: 296,401 shares worth $16.4M.
  • R.H. Bluestein & Co added most to Microsoft in Q1 2017, an estimated $18.9M increase.
  • R.H. Bluestein & Co's biggest Q1 2017 reduction was Monsanto Co, cutting an estimated $27.3M.
  • R.H. Bluestein & Co fully exited Bristol-Myers Squibb in Q1 2017, selling an estimated $24.2M.
  • R.H. Bluestein & Co's ten largest holdings make up 33% of its $1.67B portfolio in Q1 2017.
  • R.H. Bluestein & Co opened 30 new positions and closed 11 in Q1 2017.
  • R.H. Bluestein & Co's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on R.H. Bluestein & Co's 13F filing for Q1 2017, filed 12 May 2017.